Your browser doesn't support javascript.
loading
Impact of an Antibiotic Side-Chain-Based Cross-reactivity Chart Combined With Enhanced Allergy Assessment Processes for Surgical Prophylaxis Antimicrobials in Patients With ß-Lactam Allergies.
Collins, Curtis D; Scheidel, Caleb; Anam, Kishore; Polega, Shikha; Malani, Anurag N; Hayward, Alexandra; Leo, Harvey L; Shankar, Tara; Morrin, Cheryl; Brockhaus, Kara.
  • Collins CD; Department of Pharmacy Services, St Joseph Mercy Health System, Ann Arbor, Michigan, USA.
  • Scheidel C; Methods Consultants of Ann Arbor, Ypsilanti, Michigan, USA.
  • Anam K; Michigan Data Analytics, St. Joseph Mercy Health System, Ann Arbor, Michigan, USA.
  • Polega S; Department of Pharmacy Services, St Joseph Mercy Health System, Ann Arbor, Michigan, USA.
  • Malani AN; Division of Infectious Diseases, Department of Internal Medicine, St Joseph Mercy Health System, Ann Arbor, Michigan, USA.
  • Hayward A; Department of Infection Prevention and Control, St Joseph Mercy Health System, Ann Arbor, Michigan, USA.
  • Leo HL; Department of Infection Prevention and Control, St Joseph Mercy Health System, Ann Arbor, Michigan, USA.
  • Shankar T; Allergy and Immunology Associates of Ann Arbor, PC, Ann Arbor, Michigan, USA.
  • Morrin C; Allergy and Immunology Associates of Ann Arbor, PC, Ann Arbor, Michigan, USA.
  • Brockhaus K; Department of Infection Prevention and Control, St Joseph Mercy Health System, Ann Arbor, Michigan, USA.
Clin Infect Dis ; 72(8): 1404-1412, 2021 04 26.
Article en En | MEDLINE | ID: mdl-32155264
ABSTRACT

BACKGROUND:

ß-Lactam antibiotics are first-line therapy for perioperative prophylaxis; however, patient-reported allergies often lead to increased prescribing of alternative antibiotics that may increase the incidence of surgical site infections. The R-group side chain of the ß-lactam ring is responsible for allergic cross-reactivity and experts recommend the use of ß-lactams that are structurally dissimilar.

METHODS:

An internally developed, antibiotic side-chain-based cross-reactivity chart was developed and implemented alongside enhanced allergy assessment processes. This single-center, quasi-experimental study analyzed antibiotic prescribing in all adult patients with a documented ß-lactam allergy undergoing an inpatient surgical procedure between quartile (Q) 1 (2012)-Q3 (2014) (historical group) and Q3 (2016)-Q3 (2018) (intervention group). Propensity-weighted scoring analyses compared categorical and continuous outcomes. Interrupted time-series analysis further analyzed key outcomes.

RESULTS:

A total of 1119 and 1089 patients were included in the historical and intervention cohorts, respectively. There was a significant difference in patients receiving a ß-lactam alternative antibiotic between cohorts (84.9% vs 15.1%; P < .001). There was a decrease in 30-day readmissions in the intervention cohort (7.9% vs 6.3%; P = .035); however, there was no difference in the incidence of SSIs in patients readmitted (14.8% vs 13%; P = .765). No significant differences were observed in allergic reactions (0.5% vs 0.3%; P = .323), surgical site infections, in-hospital and 30-day mortality, healthcare facility-onset Clostridiodes difficile infection, acute kidney injury, or hospital costs.

CONCLUSIONS:

Implementation of an antibiotic cross-reactivity chart combined with enhanced allergy assessment processes significantly improved the prescribing of ß-lactam antibiotics for surgical prophylaxis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Antiinfecciosos Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Antiinfecciosos Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article